| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df02dc2eab1779ebc7dfb5accf94318b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81d329b9cf1274c42363bceefb5fa6f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a60649a09a47690f2c5082c03fbc2212 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-02 |
| filingDate |
2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_397a8c798c997aafceae74adbff4d6c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4187efe70e889a0eb5cf174fabca9dcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a87e5a5eba07c6995dbdc89ed6c9d62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25347e0a7689e6f5df1ccad173ec33f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d3fbacee7a7250a1e7a179d907207ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf85b21a9820429483339d59a92f08c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_148ab092cc4b0097cf7e873769ef0f88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3b0b28a051b62e12232af4dfac3d4a3 |
| publicationDate |
2019-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3468969-A1 |
| titleOfInvention |
Novel dizocilpine derivatives as peripheral nmda receptor antagonists |
| abstract |
The present invention relates to compounds of formula (I) for use as peripheral NMDA receptor antagonists. |
| priorityDate |
2016-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |